Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure

Ventricular arrhythmias (VA) are of major concern in the field of cell therapy, potentially limiting its safety and efficacy. We sought to investigate the effects of CD34(+) cell therapy on VA burden in patients with chronic heart failure (CHF). We performed registry data analysis of patients with C...

Descripción completa

Detalles Bibliográficos
Autores principales: Poglajen, Gregor, Zemljič, Gregor, Cerar, Andraž, Frljak, Sabina, Jaklič, Martina, Androcec, Vesna, Vrtovec, Bojan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719496/
https://www.ncbi.nlm.nih.gov/pubmed/31046425
http://dx.doi.org/10.1177/0963689719840351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719496/
https://www.ncbi.nlm.nih.gov/pubmed/31046425
http://dx.doi.org/10.1177/0963689719840351

Ejemplares similares